
### [NCIT:C7175](http://purl.obolibrary.org/obo/NCIT_C7175)
**Label:** Acute Myeloid Leukemia with Recurrent Genetic Abnormalities

**Subclasses:** [NCIT:C7968](http://purl.obolibrary.org/obo/NCIT_C7968) (Childhood Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C3182](http://purl.obolibrary.org/obo/NCIT_C3182) (Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C82423](http://purl.obolibrary.org/obo/NCIT_C82423) (Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214), [NCIT:C9288](http://purl.obolibrary.org/obo/NCIT_C9288) (Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C82403](http://purl.obolibrary.org/obo/NCIT_C82403) (Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C82426](http://purl.obolibrary.org/obo/NCIT_C82426) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C82427](http://purl.obolibrary.org/obo/NCIT_C82427) (Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1), [NCIT:C27757](http://purl.obolibrary.org/obo/NCIT_C27757) (Microgranular Acute Promyelocytic Leukemia), [NCIT:C27756](http://purl.obolibrary.org/obo/NCIT_C27756) (Typical Acute Promyelocytic Leukemia), [NCIT:C9287](http://purl.obolibrary.org/obo/NCIT_C9287) (Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C122688](http://purl.obolibrary.org/obo/NCIT_C122688) (Core Binding Factor Acute Myeloid Leukemia), [NCIT:C68698](http://purl.obolibrary.org/obo/NCIT_C68698) (Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C68699](http://purl.obolibrary.org/obo/NCIT_C68699) (Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C68696](http://purl.obolibrary.org/obo/NCIT_C68696) (Adult Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C68697](http://purl.obolibrary.org/obo/NCIT_C68697) (Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C6924](http://purl.obolibrary.org/obo/NCIT_C6924) (Acute Myeloid Leukemia with Variant MLL Translocations), [NCIT:C9019](http://purl.obolibrary.org/obo/NCIT_C9019) (Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C122716](http://purl.obolibrary.org/obo/NCIT_C122716) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C122717](http://purl.obolibrary.org/obo/NCIT_C122717) (Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C9018](http://purl.obolibrary.org/obo/NCIT_C9018) (Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C9155](http://purl.obolibrary.org/obo/NCIT_C9155) (Adult Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C38377](http://purl.obolibrary.org/obo/NCIT_C38377) (Acute Myeloid Leukemia with t(17;17)(q21;q21)), [NCIT:C68700](http://purl.obolibrary.org/obo/NCIT_C68700) (Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities), [NCIT:C36058](http://purl.obolibrary.org/obo/NCIT_C36058) (Acute Myeloid Leukemia with t(11;17)(q13;q21)), [NCIT:C36057](http://purl.obolibrary.org/obo/NCIT_C36057) (Acute Myeloid Leukemia with t(5;17)(q35;q21)), [NCIT:C36056](http://purl.obolibrary.org/obo/NCIT_C36056) (Acute Myeloid Leukemia with t(11;17)(q23;q21)), [NCIT:C36055](http://purl.obolibrary.org/obo/NCIT_C36055) (Acute Myeloid Leukemia with a Variant RARA Translocation), [NCIT:C129786](http://purl.obolibrary.org/obo/NCIT_C129786) (Acute Myeloid Leukemia with Mutated RUNX1), [NCIT:C129785](http://purl.obolibrary.org/obo/NCIT_C129785) (Acute Myeloid Leukemia with BCR-ABL1), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40063](http://purl.obolibrary.org/obo/NCIT_C40063) (Ovarian Low Grade Endometrioid Stromal Sarcoma))) 38.48%


